Curaleaf is overshadowing it right now, and rightfully so. Curaleaf is much older than Marimed, and is where I see us being in a few years time. Break that first $100 million, and the bigger sharks start to bite, and we show the entire investment world that Marimed is finally one of the big boys. Just my opinion, of course. As for the upcoming annual report, I'm guessing $50 million roughly.
News 
Market Data 
Discover 
